How to Read and Interpret End-Tidal Capnography Waveforms
Capnography is a great way to confirm airway device placement and monitor ventilation, but it can do so much more. Carbon dioxide (CO2) is a product of metabolism transported via perfusion and expelled through ventilation. End-tidal carbon dioxide (EtCO2) waveform monitoring allows you to measure all three simultaneously, making it the most important vital sign you use.1 To evaluate the metabolism, ventilation and perfusion of a patient through EtCO2 waveform monitoring you need to read the PQRST: proper, quantity, rate, shape and trend. Proper means that you should know the normal readings for quantity, rate, shape and tr...
Source: JEMS Patient Care - August 2, 2017 Category: Emergency Medicine Authors: Rommie L. Duckworth, LP Tags: Airway & Respiratory Patient Care Source Type: news

LimFlow touts pDVA pilot trial data, technical success rate
LimFlow today released results from the pilot study of its LimFlow percutaneous deep vein arterialization system, touting that the trial met all its safety endpoints and had a technical success rate of 100%. The French company’s pDVA system is designed to restore perfusion to ischemic feet to relieve resting pain, promote chronic wound healing, reduce amputations and restore mobility. The system uses ultrasound-guided catheters and covered nitinol stents to bypass diseased arteries and divert blood flow to the tibial vein to vascularize the affected feet. “PDVA is an innovative approach for treating no-option ...
Source: Mass Device - August 1, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Clinical Trials Diabetes LimFlow Source Type: news

Gore touts reduced portal hypertension, complications in Viatorr Tips trial
W.L. Gore & Associates today released preliminary data from a trial of its Viatorr Tips endoprosthesis with controlled expansion, touting reduced portal hypertension treatment complications when compared to the company’s legacy Tips device and bare metal stents. Data from the study was presented at The International Liver Congress 2017 in Amsterdam, the Flagstaff, Ariz.-based company said. Preliminary data from the trial, which has 21 patients currently and is still enrolling, also indicated a reduction in hospital admissions from cirrhosis-related complications, including refractory ascites and sepsis, when the ...
Source: Mass Device - August 1, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Clinical Trials Stent Grafts Stents Vascular W.L. Gore & Associates Source Type: news

CORE320: CTA and MPI for Noninvasive Assessment of CAD CORE320: CTA and MPI for Noninvasive Assessment of CAD
CT angiography and CT myocardial perfusion imaging showed as much prognostic utility in individuals with suspected coronary artery disease as did conventional angiography and SPECT imaging.Medscape Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 28, 2017 Category: Consumer Health News Tags: Radiology Viewpoint Source Type: news

Masimo wins CE Mark for RPVi
Masimo (NSDQ:MASI) said today it won CE Mark approval in the European Union for its RPVi, a multi-wavelength version of the currently available Pleth Variability Index designed to provide enhanced specificity to changes in fluid volume compared to PVi. The Irvine, Calif.-based company said that the RPVi is a noninvasive, continuous measurement designed to show dynamic changes in perfusion index that occur during respiratory cycles, which can reflect physiologic factors including vascular tone, circulating blood volume and intrathoracic pressure excursions. “Masimo rainbow technology, first announced in 2005, contin...
Source: Mass Device - July 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: Diagnostics Regulatory/Compliance Masimo Source Type: news

LimFlow launches pDVA end-stage CLI treatment trial
LimFlow said today it launched a US feasibility study of its LimFlow percutaneous deep vein arterialization system designed for treating end-stage clinical limb ischemia. LimFlow’s pDVA system is designed to restore perfusion to ischemic feet to relieve resting pain, promote chronic wound healing, reduce amputations and restore mobility. The system uses ultrasound-guided catheters and covered nitinol stents to bypass diseased arteries and divert blood flow to the tibial vein to vascularize the affected feet. The 1st patient in the trial was treated at the University of Michigan Health’s Metro Health by Dr. Jih...
Source: Mass Device - July 11, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Vascular LimFlow Source Type: news

Masimo wins CE Mark for Rainbow Super DCI-mini sensor
Masimo (NSDQ:MASI) said today it won CE Mark approval in the European Union for its Rainbow Super DCI-mini sensor designed as a reusable spot-check sensor with multiple physiologic measurements. The Irvine, Calif.-based company said that the newly cleared, reusable sensor includes for the 1st time the ability to measure total hemoglobin, carboxyhemoglobin, methemoglobin and arterial oxygen saturation. Masimo said that with the release of the Rainbow DCI-mini sensor, an expanded set of parameters can be measured with a single sensor, including SpO2, pulse rate, perfusion index, pleth variability index, SpHb, SpCO and SpMet...
Source: Mass Device - July 10, 2017 Category: Medical Devices Authors: Fink Densford Tags: Diagnostics Regulatory/Compliance Masimo Source Type: news

FDA updates on Baxter Vascu-Guard patch recall
The FDA today released an update on Baxter‘s (NYSE:BAX) voluntary recall of its Vascu-Guard peripheral vascular patch, saying that it is working with the company but that neither group has discovered a root cause for the issues, which led to a number of adverse events and 3 potential patient deaths. The Vascu-Guard patch is designed for use in vascular reconstruction surgeries including carotid, renal, iliac, femoral, profund and tibial blood vessels and arteriovenous access revisions, the FDA said. While the federal watchdog said it has yet to discover the cause of the issue, it did offer that so far, there have bee...
Source: Mass Device - July 6, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Recalls Vascular Baxter Source Type: news

PBS report targets price hike for V/Q radiotracers
Escalating costs for two radiopharmaceuticals used for ventilation/perfusion...Read more on AuntMinnie.comRelated Reading: Jubilant Pharma taps new DraxImage president Jubilant DraxImage, Cyclopharm ink deal Jubilant DraxImage hikes radiotracer prices in U.S. Jubilant DraxImage short on technetium kits DraxImage, Positron to boost radiopharma supplyComments: 6/30/2017 6:19:02 PMNYK Free Market health care at work. Jubilant DraxImage is the only game in town and can charge whatever they want. Which is now 10x as much. Should we stop recommending/providing VQ scans to show the company these prices are unviable? (...
Source: AuntMinnie.com Headlines - June 30, 2017 Category: Radiology Source Type: news

CT technology shows how blood flow can predict effectiveness of ovarian cancer treatment
(University of Western Ontario) Technology developed at Western University and Lawson Health Research Institute can provide a new window into whether or not patients are responding to treatment for advanced ovarian cancer. A multi-center clinical trial has demonstrated that CT Perfusion, which measures blood flow and blood volume to tumors associated with ovarian cancer, can provide an accurate prediction of how well a treatment is working, allowing physicians the opportunity to better plan treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 28, 2017 Category: International Medicine & Public Health Source Type: news

Biotronik wins CE Mark for 3T scans with ProMRI pacers
Biotronik said today it won CE Mark approval in the European Union for 3 Tesla full-body scans with its latest range of MR conditional pacemakers featuring its ProMRI technology. The new clearance covers single and dual chamber pacemakers from the Edora, Evity and Enitra series during ultra-high field MRI scans. The approval makes it possible to scan areas of the body typically off limits to pacemaker patients, Biotronik said. “As 3 T MRI becomes increasingly prevalent in the management of a variety of diseases, it is vital that pacemaker patients also have access to this invaluable mode of imaging. Thoracic imaging...
Source: Mass Device - June 13, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Regulatory/Compliance Biotronik Source Type: news

GE Healthcare CEO Flannery promoted to GE ’ s corner office | Personnel Moves – June 12, 2017
Former GE Healthcare (NYSE:GE) head John Flannery will be stepping into the corner office for all of GE, replacing Jeff Immelt who is stepping aside after 16 years as head of the large conglomerate. The CEO transition will go into effect Aug. 1, while Flannery will also take over as board chair after Immelt retires on Dec. 31, GE said. “I want to start with a fresh look around the company overall and I think with a sense of urgency. There’s so many things we do well and have always done well and there’s clearly some areas we need to improve on and improve on quickly. No one’s happy with the stock p...
Source: Mass Device - June 12, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Adherium Limited Apple Delphi Medical Systems GE Healthcare Mazor Robotics royal-philips Siemens Terumo Source Type: news

Horsham woman undergoes grueling form of chemotherapy
Sally Barnes, from Horsham, West Sussex, chose to undergo a treatment called Isolated Limb Perfusion at the Royal Marsden Hospital in London to overcome her skin cancer battle. (Source: the Mail online | Health)
Source: the Mail online | Health - June 7, 2017 Category: Consumer Health News Source Type: news

7 medtech stories we missed this week: May 26, 2017
[Image from unsplash.com]From Merck’s new licensing agreement to surgical study data being touted, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Merck inks exclusive licensing agreement for Alzheimer’s antibody Merck announced in a May 25 press release that it has entered an exclusive worldwide license agreement with Teijin Pharma. The licensing agreement is going to help with the development, manufacture and commercialization of an investigation preclinical antibody candidate that targets the protein tau. Merck will have exclusive worldwide rights to develop, manufa...
Source: Mass Device - May 26, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Patient Monitoring Pharma Pharmaceuticals Research & Development Surgical EarlySense Janssen Pharmaceuticals Life Spine Inc. Masimo MedTech Merck Midmark Procept BioRobotics Shenzhen Lachesis Mhealth Teijin Pharma Thermi Source Type: news

WA Lawmakers Ask University to Stop Training Paramedics on Live Pigs
It's a procedure in which paramedics cut into a person's neck to create an emergency airway. And, at the University of Washington, prospective paramedics learn to do it on live pigs. Now some Washington lawmakers want to end to that practice.   Paramedics don’t need to cut open the throat of a pig when they have other options,” Rep. Sherry Appleton, D-Poulsbo, said. “I would like to see the university take responsibility and to search out different ways to solve these situations.   "It seems to me that we need to be more considerate.”   Appleton is one of eight members of the House who signed a ...
Source: JEMS: Journal of Emergency Medical Services News - May 1, 2017 Category: Emergency Medicine Authors: A.J. Heightman, MPA, EMT P Tags: Training News Source Type: news